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Assessment of the findings on the existence of complications in
brucellosis
Cemal BULUT1, Meltem Arzu YETKİN1, Gülruhsar YILMAZ1, Fatma Şebnem ERDİNÇ1,
Çiğdem ATAMAN HATİPOĞLU1, Sami KINIKLI1, Behiç ORAL1, Necla TÜLEK2, Ali Pekcan DEMİRÖZ1

Aim: Brucellosis is a prevalent disease in Turkey. The object of this study was to assess the findings in brucellosis cases
with and without complications.
Materials and methods: A total of 324 patients diagnosed with brucellosis between 1999 and 2005 were reviewed
retrospectively. The diagnosis of brucellosis was established serologically and/or by positivite blood culture. Epidemiologic
features, clinical symptoms, and laboratory findings of the patients were assessed in both complicated and noncomplicated
brucellosis cases by univariate and multivariate analysis.
Results: The mean age of patients was 44.0 ± 18.3 years (range 15-83 years). In addition, 56% of the patients were male.
Animal husbandry (62.7%) and consumption of raw milk and/or fresh cheese (27.7%) were identified as being the main
risk factors for brucellosis. Fever, malaise, sweating, and arthralgia were the most frequent clinical symptoms. The most
common physical findings were fever, hepatomegaly, and splenomegaly. Complications were detected in 142 of 324 cases
(43.8%). Osteoarticular involvement (25.9%) was the most common complication. Dealing with animal husbandry, living
in a rural area, being between 31 years and 50 years of age, and an elevated C-reactive protein (CRP) level were
significantly associated with the existence of complications by univariate analysis (P < 0.05). Elevated CRP level remained
independently associated with complications by multivariate analysis (P < 0.05).
Conclusion: Elevated CRP levels, in accordance with clinical manifestations of the patient, may be a sign of complications,
and needs further investigation.
Key words: Brucellosis, epidemiology, diagnosis, complication

Bruselloz hastalarında komplikasyonların varlığının belirlenmesinde bulguların
değerlendirilmesi
Amaç: Bruselloz ülkemizde yaygın olarak görülen bir hastalıktır. Bu çalışmada komplikasyonla seyreden ve seyretmeyen
bruselloz olgularında klinik ve laboratuar bulgularının değerlendirilmesi amaçlandı.
Yöntem ve gereç: Bu çalışmada 1999 ile 2005 yılları arasında bruselloz tanısıyla kliniğimizde takip edilen hastalar
retrospektif olarak değerlendirildi. Bruselloz tanısı serolojik olarak veya kan kültüründe etkenin izolasyonu ile konuldu.
Komplikasyon gelişen ve gelişmeyen hastaların epidemiyolojik, klinik ve laboratuvar özellikleri tek değişkenli ve çok
değişkenli yöntemlerle analiz edildi.
Bulgular: Hastaların yaş ortalamaları 44,0 ± 18,3 yıl idi (yaş aralığı 15-83 yıl). Hastaların % 56’sı erkekti. Brusellozun bulaş
yolu olarak hastaların % 67,2’sinde hayvancılık, % 27,7’sinde taze süt ve/veya peynir tüketimi idi. Ateş, kırgınlık terleme
ve artralji en sık görülen semptomlardı. Ateş, hepatomegali ve splenomegali ise en sık saptanan fizik muayene bulguları
idi. Hastaların 142’sinde (% 43,8) komplikasyon saptandı. Osteoartiküler tutulum (% 25,9) en sık saptanan komplikasyon
idi. Tek değişkenli analizlerde hayvancılıkla uğraşma, kırsal bölgede yaşama, yaşın 31 ile 50 arasında olması ve yüksek
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C-reaktif protein (CRP) seviyesi komplikasyon gelişimi ile ilişkili bulundu (P < 0,05). Çok değişkenli analizde ise sadece
yüksek CRP seviyesi komplikasyon varlığı ile ilişkili bulundu (P < 0,05).
Sonuç: Yüksek CRP seviyesi hastaların klinik bulguları ile birlikte değerlendirildiğinde bir komplikasyonun varlığının
göstergesi olabilir ve bu hastalarda ileri araştırmalar gerekebilir.
Anahtar sözcükler: Bruselloz, epidemiyoloji, tanı, komplikasyon

Introduction
Brucellosis is still endemic in Mediterranean
countries, in Africa, in the Middle East, and Central
Asia (1). In Turkey, human brucellosis is particularly
an endemic disease. According to the database of the
Turkish Ministry of Health, 15,000 cases annually
(incidence 22/100,000) of human brucellosis have
been reported (2).
Brucellosis is a systemic infection in which any
organ or system of the body can be involved. The
disease is characterized by non-specific symptoms.
Protean clinical manifestations cause difficulty in
diagnosis. Late diagnosis can lead to serious
complications and significant morbidity. The
musculoskeletal system, hepatobiliary system, and
nervous system are frequently affected (3).
The object of this study was to assess the findings
of brucellosis cases with and without complications.
Materials and methods
This retrospective study was conducted at the
Department of Infectious Diseases and Clinical
Microbiology of The Health Ministry Ankara
Training and Research Hospital between January 1999
and June 2005. Patients over 15 years of age,
diagnosed and treated for brucellosis, were enrolled
in the study. All patients were evaluated for the
systemic involvements of brucellosis. Demographic
characteristics, presence, duration of clinical
symptoms at admission, history of ingestion of raw
milk or milk products, pertinent physical examination
findings, and laboratory test results were recorded.
Our hospital is one of the major state hospitals in the
city, serving not only the 4,500,000 inhabitants of
Ankara, but also it is the referral hospital for 11 cities
in Central Anatolia.
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Diagnosis of brucellosis: Diagnosis was established
by one of the following criteria: (1) isolation of
Brucella spp. from blood samples, (2) a clinical and
epidemiological presentation consistent with
brucellosis in the presence of a standard tube
agglutination test (STA) equal to or higher than 1:160,
or (3) a 4-fold increase in titers of STA within 4 weeks.
A seroagglutination test was carried out in all
patients. All the blood samples were cultured in
BACTEC 9050 system and incubated for at least 21
days. A complete blood count, erythrocyte
sedimentation rate (ESR), C-reactive protein (CRP),
liver, and renal function tests were also performed.
The accepted normal range of the ALT, AST, and CRP
were 0-35 U/L, 0-34 U/L, and 0-0.8 mg/dL,
respectively. The normal upper limit for ESR was
accepted as 20 mm/h for males, and 15 mm/h for
females. A hemoglobin level lower than 12 g/L was
defined as anemia, and a platelet level lower than
150,000/μL was defined as thrombocytopenia.
Patients with brucellosis were classified as acute (< 8
weeks), sub-acute (8-52 weeks), and chronic (> 52
weeks) according to the duration of clinical symptoms
(4).
Definition of complications: Sacroiliitis,
spondylitis, and peripheral arthritis were diagnosed
by radiographic abnormalities, detected by one of the
following: X-ray, computed tomography, magnetic
resonance imaging, or bone scan. Neurobrucellosis
includes meningitis, encephalitis, myelitisradiculoneuronitis, brain abscess, epidural abscess,
and meningovascular syndromes. Meningitis was
diagnosed by isolation of Brucella spp. from
cerebrocpinal fluid (CSF), and/or the demonstration
of antibodies to Brucella spp. in the CSF (at any titer)
in the presence of any abnormality of the CSF.
Epididymo-orchitis was diagnosed by swelling and
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tenderness of scrotal skin, testis, and epididymis with
confirmation by sonography. The hematological
involvement of brucellosis includes anemia,
leucopenia,
and
thrombocytopenia.
Bronchopneumonia, pleural effusion, solitary
nodules, hilar, and paratracheal lymphadenopathy, in
the absence of other causes, were considered as
respiratory tract involvement. Endocarditis was
diagnosed by the detection of vegetations using
echocardiography in the patient with anemia, elevated
ESR levels, and cardiac murmur. Uveitis was accepted
as ocular involvement (3).
The patients were classified into 2 sub-groups
according to the presence of complications.
Statistical analysis
Data were analyzed using SPSS version 10.0. Chisquare test and Mann-Whitney U test were
performed, with P-values of < 0.05 accepted as
significant. Logistic regression enter method was used
for multivariate analysis. Correlation was evaluated
by the Spearman correlation coefficient. The
diagnostic value of the CRP level for detection of
complication was assessed by calculating the area
under receiver operating characteristics (ROC) curve.
A cut-off point was selected from the ROC curve to
identify the presence of complication.

Results
A total of 324 patients were included in the study.
Brucellosis was more frequent in male patients;
furthermore, 180 (56%) were male and 144 (44%)
patients were female. The mean age of patients was
44.0 ± 18.3 years (range 15-83 years). The possible
source of infection was identified in 293 patients, 203
(62.7%) of whom had direct contact with animals or
worked with animal products, and 90 (27.7%) of
whom had consumed unpasteurized dairy products,
especially fresh cheese. Contact with livestock was
more likely in male patients (64.5%), whereas a
history of ingestion of nonpasteurised products was
detected in female patients (53.3%). No source was
identified in the remaining 9.6% of patients. The
percentage of patients with a family history of
brucellosis, or presence of brucellosis cases in the
surrounding area, was 36.7%.
Fifty-four percent of patients lived in rural areas,
whereas 46% of patients lived in urban areas. Most of
the cases were detected during the summer months
and early autumn. Acute disease was found in 61.1%
of patients, whereas 24.1% and 14.8% of patients had
subacute and chronic forms of the disease,
respectively.
Complications were detected in 142 of 324 (43.8%)
cases (Table 1). Osteoarticular involvement was the

Table 1. Complications of 324 patients with brucellosis.
Complication

Acute cases

Chronic and
Subacute cases

No. (%)
of cases

Osteoarticular

50 (59.5)

34 (40.5)

84 (59.1)

Neurological

13 (65)

7 (35)

20 (14.1)

Urogenital*

14 (70)

6 (30)

20 (20.8)

Respiratory

4 (50)

4 (50)

8 (5.6)

Hemathologic

4 (67)

2 (33)

6 (4.2)

Ocular

1 (33)

2 (67)

3 (2.1)

Cardiovascular

1 (100)

0 (0)

1 (0.7)

87 (61.2)

55 (38.7)

142 (100)

Total
* male patients
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most frequent complication, being present in 84 cases,
representing 25.9% of all patients, and 59.2% of the
complicated cases. Neurologic involvement was
present in 20 patients, representing 6.2% of all
patients. All of the neurobrucellosis cases were
presented with meningitis. Twenty male patients
(11.1% of all male patients) had genitourinary
involvement. Respiratory, ocular, and cardiovascular

complications were the other complications. Most of
the complications were detected in acute cases.
Fever, malaise, sweating, and arthralgia were the
most common clinical symptoms. They were detected
in 73.8%, 71%, 69%, and 52% of patients, respectively.
Other clinical features of the patients are given in
Table 2. Fever, splenomegaly, and hepatomegaly were
the most frequent physical findings.

Table 2. Epidemiological, clinical, and laboratory features of 324 patients with brucellosis.
Characteristics

With
Complications
N = 142

With
Complications
N = 182

Total no.
(%)
cases

P

87/55
43.8 ± 17.5

93/89
44.0 ± 18.7

180/144

0.068
0.914

38 (26.8)
52 (36.6)
52 (36.6)

63 (34.6)
43 (23.6)
76 (41.8)

101 (31.2)
95 (29.3)
128 (39.5)

0.035

Occupation
Animal husbandry
Other

94 (66.2)
48 (33.8)

89 (48.9)
93 (51.1)

183 (56.5)
141 (43.5)

0.002

Living area
Urban
Rural

50 (35.5)
91 (64.5)

96 (53.9)
82 (46.1)

146 (45.8)
173 (54.2)

0.001

Possible source of infection
Animal husbandry
Consuming raw milk
Unknown

102 (71.8)
28 (19.7)
12 (8.5)

101 (55.5)
62 (34.1)
19 (10.4)

203 (62.7)
90 (27.8)
31 (9.6)

0.008

Duration of symptoms
< 2 months
> 2 months

87 (61.3)
55 (38.7)

111 (61.0)
71 (39.0)

198 (61.1)
126 (38.9)

0.953

Clinical features
Fever
Malaise
Sweating
Arthralgia
Chills
Back pain
Myalgia
Headache
Weight loss

103 (79.2)
109 (76.8)
104 (73.2)
68 (47.9)
75 (52.8)
68 (47.9)
66 (46.5)
51 (35.9)
45 (31.7)

136 (84.0)
121 (66.5)
120 (65.9)
101 (55.5)
76 (41.8)
78 (42.9)
79 (43.4)
58 (31.9)
49 (26.9)

239 (73,8)
230 (71.0)
224 (69,1)
169 (52,2)
151 (46.6)
146 (45,1)
145 (44,8)
109 (33.6)
94 (29.0)

0.298
0.058
0.158
0.174
0.062
0.367
0.581
0.444
0.348

Signs
Fever
Splenomegaly
Hepatomegaly

45 (32.4)
33 (23.2)
25 (17.6)

42 (24.3)
42 (23.1)
32 (17.6)

87 (26.9)
75 (23.1)
57 (17.6)

0.113
0.973
0.996

Gender M/F
Age
Age groups
15-30
31-50
> 51
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Laboratory findings are shown in Table 3. Anemia
was detected in 132 (40.7%), thrombocytopenia in 37
(11.4%), leucopenia in 36 (11.1%), and elevated CRP
levels in 208 patients (64.2%). Agglutination titer was
> 1/160 in 310 patients (95.7%), between 1/160 and
1/40 in 13 (4%) patients, and negative in 1 patient.
Blood cultures, were positive in 118 (36.4%) out of
324 patients. Brucella spp. isolates were detected in
37.3% of patients with systemic involvement. The
Brucella spp. isolation rate was highest in patients with
hematologic involvement (83%). The isolation rates
of Brucella spp. in patients with urogenital,
respiratory,
neurologic,
and
osteoarticular
involvements were 50%, 50%, 35%, and 30%,
respectively.
Clinical symptoms and laboratory findings of the
patients with and without complications were
compared (Tables 2 and 3). No statistically significant
difference was found in age, or the duration of
symptoms of the patients with and without
complications (P > 0.05). When the patients were
grouped according to age, the systemic involvement
rate was higher in patients between 31 and 50 years
of age, and this difference was statistically significant
(P = 0.035). Although complications were observed
more frequently in male brucellosis cases when
compared to female patients, no statistically
significant difference was detected (P = 0.068).
Although malaise, sweating, chills, myalgia, and

headaches were detected more frequently in patients
with complications, statistically significant differences
were not detected between the groups (P > 0.05). On
the other hand, dealing with animal husbandry, living
in a rural area, and elevated CRP levels were
significantly associated with complications formed by
univariate analysis (P < 0.05). The median level of
CRP in patients without system involvement was 1.2
mg/dL, whereas the value for the patients with system
involvement was 2.3 mg/dL. The median levels of
CRP values in patients with hematologic, urogenital
and osteoarticular involvements were as follows: 9.6
mg/dL, 7.9 mg/dL, and 2.5 mg/dL, respectively. When
CRP levels were evaluated according to the duration
of symptoms, median CRP levels were 5.3 mg/dL, 3.4
mg/dL, and 4.5 mg/dL in acute, subacute, and chronic
cases, respectively.
By multivariate analysis, elevated CRP levels
remained independently associated with systemic
involvement (P < 0.05). A correlation was found
between the serum CRP level and presence of
complications (r = 0.146, P = 0.009). The diagnostic
value of the serum CRP level for systemic involvement
was assessed by the area under the ROC curve
(AUROC at 0.58, 95% CI 0.52-0.65). Based on
AUROC, 3.5 mg/dL was calculated as a cut-off point
to predict complications in brucellosis patients. The
sensitivity and specificity of this cut-off value were
44% and 70%, respectively.

Table 3. Laboratory features of Brucellosis patients with and without complications.
Findings

White blood cell
< 4.5 × 103/mm3
4.5-11 × 103/mm3
> 11 × 103/mm3
Anemia
Thrombocytopenia
ALT elevation
AST elevation
Elevated ESR
Elevated CRP
Positive blood culture

Complicated
N = 142

Noncomplicated
N = 182

Total no.
(%) cases

P

17 (11.1)
119 (83.8)
6 (4.2)
66 (46.7)
19 (12.7)
37 (26.1)
34 (23.9)
101 (71.1)
101 (71.1)
53 (37.3)

19 (11.1)
158 (86.8)
5 (2.7)
66 (36.2)
18 (10.4)
50 (27.5)
48 (26.4)
125 (68.7)
107 (58.8)
65 (35.7)

36 (11.1)
277 (85.5)
11 (3.4)
132 (40.7)
37 (11.4)
87 (26.9)
82 (25.3)
226 (69.8)
208 (64.2)
118 (36.4)

0.684

0.060
0.651
0.775
0.618
0.634
0.022
0.765
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Discussion
It is important to determine the epidemiological
features of the illness for the control of the infection.
Brucellosis is an important health problem in this
country, with numerous reports of cases from
different regions(4-7).
Three hundred twenty-four brucellosis patients
were evaluated in this study. The majority of our
patients lived in rural areas and had direct contact
with animals, or worked with animal products.
Consumption of fresh cheese prepared with
unpasteurized milk was the second important
epidemiological feature for the acquiring of infection.
The distribution of risk factors in our series was
different from that of Hasanjani et al. (8), who
reported that only a small percent of patients (11.3%)
could be linked to a common risk factor such as
working with animals. As previously reported, we
observed the prevalence of brucellosis to be higher in
male patients (9,10). A family history of brucellosis
was detected in approximately one-third of our
patients. This could be due to sharing the same
environment, livestock contact, and dairy product
consumption as reported by Almuneef et al. (11).
Symptoms suggesting brucellosis are protean and
nonspecific, yet commonly include fever, chills,
sweating, headache, fatigue, arthralgia, back pain,
myalgia, and weight loss (12,13). The physical
findings included fever in 80%-90% of the patients
and
hepatosplenomegaly
in
20%-30%,
lymhpadenopathy 8%-25%, and osteoarticular
findings in 12%-43% from different studies (12-14).
Routine laboratory tests are usually unremarkable or
nonspecific. The frequency of symptoms, signs and
laboratory findings in our patients were similar to
those reported in the literature (5,7,12-15).
Brucellosis is a systemic infection in which any
organ or system can be involved. When involvement
of a spesific organ predominates, the disease is often
termed focal or complicated. However, it is always
difficult to determine what is a complication, and
what is considered an expected manifestation (3). The
complication rate of brucellosis varies between 27.7%
and 49% in large surveys (5,9,12,15,16). Our rate was
43.8%, which was near the top of the previously
reported rates. Our hospital is a tertiary care hospital
in the Central Anatolia region; uncomplicated cases
280

were treated in their hometown, whereas most
patients with complications were referred to us, which
might be the cause of our relatively high incidence
rate.
Osteoarticular involvement such as sacroiliitis,
spondylitis, and arthritis are the most frequent focal
complications, with a frequency of 21% to 37.5%
(5,12,17-19). Similar to previous studies,
osteoarticular manifestations were found to be 25.9%
in our patients.
Neurologic involvement was reported in 3% to 5%
in most studies, but may mount up to 17.8% in endemic
areas
(20-23).
Clinical
manifestations
of
neurobrucellosis vary widely, in which meningitis is the
most frequent manifestation (3). Neurologic
complications were detected in 6.2% of our patients. All
of them had meningitis as previously reported (24).
Unilateral epididymo-orchitis is a common
genitourinary complication in men (23). We detected
epididymo-orchitis in 11.1% of male brucellosis patients
that were reported previously (25). Lobar pneumonia,
bronchitis, pulmonary nodules, hilar adenopathy, and
pleural infection all have been reported as respiratory
complications of brucellosis (3,12,26). Pulmonary
involvement was noted in 2.5% of our patients.
In our study, animal husbandry and living in rural
area were found as significant findings for the
existence of complications in brucellosis by univariate
analysis, but not in multivariate analysis. For people
living in rural areas of Turkey, animal related jobs
such as animal raising are the main way to earn their
living. It is known that people involved in animal
husbandry are at an increased risk of contracting
brucellosis (3). That is compatible with our
multivariate analysis result.
There is no definitive means of predicting which
brucellosis patients will develop complications.
However, in a study by Colmenero et al. (12)
diagnostic delay, elevated sedimentation rates, and
elevated alpha-2 globulin levels correlated with the
development of focal complications. We found no
difference in sedimentation rates and the duration of
symptoms as risk factors for complications. However,
we found elevated CRP levels greater than 3.5 mg/dL
were associated with the presence of complications.
Although the serum CRP levels is a nonspecific
marker of inflammation, it was thought that using a
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new cut-off value for CRP levels could help the
physician in further investigation of the
complications. CRP levels were found to be higher in
hematological and urogenital complication groups.
When each complication was evaluated according to
the CRP cut-off levels in hematological and urologic
complication groups, 83% and 75% of patients have
higher levels of CRP. Although the skeletal
involvement was the most frequent complication, the
median CRP level in this group was only moderately
high. Although Al-Kassab et al. reported lower levels
of CRP in osteoarticular involvement of brucellosis,
elevated CRP levels were expected in the complicated

cases, and our results supported this finding (27). In
a previous study from our center, elevated CRP levels
were associated with complications in brucellosis (28).
The complications of brucellosis may cause high
morbidity. It may be useful to identify the possible
indicator or indicators that are associated with the
complicated form of the disease for early diagnosis
and appropriate treatment. In our study, an elevated
CRP level was found as a significant marker in
patients with complications. In conclusion, elevated
CRP levels, in accordance with clinical manifestations
of the patient, may be a sign of complications, and
needs further investigation.
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